MacOrtho is pleased to announce that we have secured definitive funding from the Canadian Institutes of Health Research (CIHR) for the HEALTH Trial (PI: Dr. Mohit Bhandari). The HEALTH trial is a multi-centre randomized controlled trial of 1,434 patients evaluating total hip arthroplasty (THA) versus hemi-arthroplasty (HA). The primary objective of the HEALTH trail is to compare revision surgery rates at 24 months in patients over 50 years of age who are treated with either total hip arthroplasty (THA) or hemi-arthroplasty (HA). Secondary objectives include comparing health-related quality of life, functional outcomes and mobility in patients receiving either THA or HA.
HEALTH was first funded as a pilot study by CIHR in 2008 and since then enthusiasm and support for the trial has resulted in additional funding obtained by HEALTH American Investigators (National Institutes of Health 2008), Dutch Investigators (ZonMw, 2008) and the Sophie Mindes Foundation for Orthopaedic Research in Norway (2012). Funding to date has supported the recruitment of 348 patients. Since its inception, HEALTH has raised a total of approx 4.5 million dollars.
Recent funding obtained from the National Institutes of Health (2012) and this new CIHR funding will support the definitive sample of 1,434 patients. We are looking forward to increasing the momentum of the HEALTH trial with this new funding.